Gates Package — page 862
of 1375 pages
← p.861 p.863 → · this page in the original PDF · package
From:
To:
"Dieffenbach, Carl (NIH/NIAID) [E]" [I
Oniaid.nin.gov>
"Collins, Francis (NIH/NHG!
E]" HE nib. gov>, "Gibbons, Gary
(NIH/NHLBD)
[E]"
nih.gov>, "Panepinto, Julie (NIH/NHLBD [E]"
ih.gov>, "Fauci, Anthony (NIH/NIAID) [E]" |f@niaid.nin.gov>
Cc: "Tabak, Lawrence (NIH/OD) [E]" HE oni. gov>, "Schwetz, Tara (NIH/OD) [E]"
nih.gov>, "Auchincloss, Hugh (NIH/NIAID) [E]"
niaid.nih.gov>, "Harper, Jill (NIH/NIAID) [E]" Jo:
Subject: RE: Seeing Bill Gates tomorrow
Date: Tue, 27 Sep 2022 09:57:32 -0400
Importance: Normal
niaid.nih.gov>
Francis,
We have continued to meet with Mike and his team. One of his team members is coming for a visit in October so we can
have a face to face deep dive.
Since Sunnylands the Temple group initiated the phase one of a anti-HIV CRISPR trial in Philadelphia, part of the NIAID
Collaboratory. We have reviewed a set of grants looking new and improved delivery systems for gene therapies. We plan
to fund 3-4 and the details will be announced in the new fiscal year. We are expanding in 2023 the process for sites in
LMICs to apply for assistance to support cure trials including but not limited to gene-based technologies. The first
iteration of this strategy has been completed, now on to version 2.0. Last, the plans for an bNAb treatment and cure trial
in Africa with BMGF is moving forward. Waiting for BMGF to finish production of the bNAbs.
This continues to be parallel and complementary activities with BMGF.
Best regards,
Carl
From: Collins, Francis (NIH/NHGRI) [E] ©
Sent: Tuesday, September 27, 2022 6:48 AM
To: Gibbons, Gary (NIH/NHLBI) [E]
Dieffenbach, Carl (NIH/NIAID) [E]
Cc: Tabak, Lawrence (NIH/OD) [E]
Subject: Seeing Bill Gates tomorrow
ih.gov>
nih.gov>; Panepinto, Julie (NIH/NHLBI) [E]
niaid.nih.gov>; Fauci, Anthony (NIH/NIAID) [E]
niaid.nih.gov>
nih.gov>; Schwetz, Tara (NIH/OD) [E]
i
Hi all,
Bill Gates is at the White House tomorrow and asked to see me at 9 AM. Among the topics we will likely discuss is the
HIV-SCD joint NIH-BMGF effort to develop cures that will be applicable in low income settings. Are there any new
developments since the Sunnylands meeting back in May? Bill
will
likely ask about the future of this partnership.
Thanks, Francis
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/862
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:email:00748 | 2022-09-27 | 862–863 | |
| RE: Seeing Bill Gates tomorrow | 2022-09-27 | 862 |